Neonmind Biosciences Stock Return On Asset
| NMDBFDelisted Stock | USD 0.50 0.00 0.00% |
NeonMind Biosciences fundamentals help investors to digest information that contributes to NeonMind Biosciences' financial success or failures. It also enables traders to predict the movement of NeonMind Pink Sheet. The fundamental analysis module provides a way to measure NeonMind Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NeonMind Biosciences pink sheet.
NeonMind |
NeonMind Biosciences Company Return On Asset Analysis
NeonMind Biosciences' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current NeonMind Biosciences Return On Asset | -1.88 |
Most of NeonMind Biosciences' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NeonMind Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, NeonMind Biosciences has a Return On Asset of -1.8822. This is 78.49% lower than that of the Healthcare sector and 92.02% lower than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.
NeonMind Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NeonMind Biosciences' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of NeonMind Biosciences could also be used in its relative valuation, which is a method of valuing NeonMind Biosciences by comparing valuation metrics of similar companies.NeonMind Biosciences is currently under evaluation in return on asset category among its peers.
NeonMind Fundamentals
| Return On Equity | -37.22 | |||
| Return On Asset | -1.88 | |||
| Operating Margin | 735.17 % | |||
| Current Valuation | 799.08 K | |||
| Shares Outstanding | 35.82 M | |||
| Price To Book | 12.19 X | |||
| Price To Sales | 18.10 X | |||
| Gross Profit | (84.45 K) | |||
| EBITDA | (6.65 M) | |||
| Net Income | (7.21 M) | |||
| Cash And Equivalents | 89.22 K | |||
| Total Debt | 450.01 K | |||
| Debt To Equity | 1.58 % | |||
| Current Ratio | 0.59 X | |||
| Book Value Per Share | (1.22) X | |||
| Cash Flow From Operations | (5.82 M) | |||
| Earnings Per Share | (0.14) X | |||
| Beta | -1.12 | |||
| Market Capitalization | 272.23 K | |||
| Total Asset | 1.34 M | |||
| Z Score | -13.2 | |||
| Net Asset | 1.34 M |
About NeonMind Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NeonMind Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeonMind Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeonMind Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in NeonMind Pink Sheet
If you are still planning to invest in NeonMind Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeonMind Biosciences' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |